Provocative gene therapy strategy for the treatment of hepatocellular carcinoma
β Scribed by Frederick Askari; James Wilson
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 260 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Gene therapy, which is the deliberate transfer of DNA for therapeutic purposes, can be defined as the in situ production of a therapeutical material within the diseased cells. The eye is an ideal target for gene therapy, as it is confined to a small space, separated by the retina-blood barrier from
For an approach of gene therapy for hepatocellular carcinoma (HCC), transcriptional regulatory sequence (TRS) of either alpha-fetoprotein (AFP) or albumin has been used for targeting cancer cells. To examine the feasibility of using TRSs of these genes for possible gene therapy of HCCs, the cellular
## Abstract ## Background and Objectives Vascular infiltration (VI) is an important prognostic factor for hepatocellular carcinoma (HCC) and predictive parameters are necessary to preoperatively decide treatment strategies in patients with HCC. ## Methods Relationships between presence and degre
Hepatocellular carcinoma (HCC) in the setting of cirrhosis continues to increase in both the United States and abroad because of the widespread incidence of hepatitis B and C. Before the advent of transplantation, liver resection was the only method to achieve cure. However, resection is associated
## Abstract ## Background and Objectives The recurrence of hepatocellular carcinoma (HCC) after percutaneous ablation is poorly evaluated. ## Methods Thirtyβsix cases of recurrence after percutaneous ablation (PA) (Group 1) are compared to those after surgery, treated with reβresection (26 patie